Article
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines
2020-01-29
Abstract excerpt
Starting from December 2019, a novel coronavirus, named 2019-nCoV, was found to cause Severe Acute Respiratory (SARI) symptoms and rapid pandemic in China. With the hope to identify candidate drugs for 2019-nCoV, we adopted a computational approach to screen for available commercial medicines which may function as inhibitors for the M pro of 2019-nCoV. Up to 10 commercial medicines that may form hydrogen bounds t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e7b15717-b319-5ff6-801c-2f858e60b559
- DOI
- 10.1101/2020.01.29.924100
